leisure time -WSS

leisure time

author：explore 2025-10-02 05:30:57 - browse：525

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Free speech concerns arise in wake of journal editor Eisen's firing

leisure time

WSS

Why don't Americans have at

Abortion clinic in Cancun will cater to Americans

Juul documents reveal insider tactics on political lobbying

Medicare solvency divides Republicans at the presidential debate

Having children helps parents live longer, especially after age 80

Ebola vaccine can save some who are already sick, per new study

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

23andMe had bad news about my health. I wish a person had delivered it

STAT Executive Editor Rick Berke on STAT's 8th birthday

Jerome Adams on the need for new antivirals for Covid

MoonLake credibility takes another hit with mid

Novavax promises a turnaround & Lilly roils the obesity market

Senate panel clears PBM, hopsital reforms

Medical leaders decry Supreme Court decision on affirmative action

Just how powerful is the placebo effect?

Continuity nursing helped my family in our darkest PICU moments

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

explore

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Study: New antibiotic targets gonorrhea as well as last existing drug

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Why don't Americans have at

FDA approves Recor Medical high blood pressure device

leisure time

explore

focus

explore